x

Búsqueda de un proyecto

* (*) Campo obligatorio

65 Resultado(s)

Ordenados por

Financiado por un miembro del IRDiRC =

Proyectos de investigación

ALEMANIA

Bayern
MARTINSRIED

Cellular Toxicity of Polyglutamine Proteins in Neurodegenerative Disease
Max-Planck-Institut für Biochemie
Abteilung zelluläre Biochemie

ITALIA

LOMBARDIA
MILANO

Financiado por un miembro del IRDiRCA drosophila model to study the neurodegenerative disease Dentatorubral-pallidoluysian atrophy
IRCCS Ospedale San Raffaele
Divisione di Genetica e Biologia Cellulare - Dipartimento di Genomica Funzionale

JAPON

JAPAN
ADDRESS : NOT PROVIDED - JP

SUECIA

Stockholms läns landsting
STOCKHOLM

The role of an atrophin-brakeless protein complex in gene regulation and neurodegeneration in particularly
Stockholm University
Department of Molecular Biosciences, The Wenner-Gren Institute (MBW)

ALEMANIA

Schleswig-Holstein
LÜBECK

Phenotypic spectrum and molecular characterization of Movement disorders
Universität Lübeck
Institut für Neurogenetik

FRANCIA

ILE-DE-FRANCE
PARIS

Financiado por un miembro del IRDiRCSPATAX-QUEST: Identification of new causative genes in spinocerebellar degenerations by combination of whole genome scan, next-generation sequencing and biological validation in vitro and in vivo
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

ITALIA

LAZIO
ROMA

SPATAX: European network for hereditary spinocerebellar degenerative disorders
Fondazione EBRI
Istituto di Neurobiologia e Medicina Molecolare

ITALIA

PIEMONTE
TORINO

Identification of the gene responsible for a novel form of autosomal dominant spinocerebellar ataxia
A.O. Città della Salute e della Scienza di Torino - Ospedale Molinette
Genetica Medica

PORTUGAL

NORTE
PORTO

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Centro de Genética Preditiva e Preventiva

PORTUGAL

NORTE
PORTO

Clinical implications of genetic factors causing neurodegenerative diseases characterized by movement or cognitive dysfunction.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
PORTO

Mapping and identification of new disease genes in autosomal dominant spinocerebellar ataxias
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
PORTO

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
SANTA MARIA DA FEIRA

REINO UNIDO (EL)

Berkshire
READING

REINO UNIDO (EL)

Greater London
LONDON

Endogenous Cerebellar Human Stem Cells and their Potential Neuroregenerative Role in Inherited Ataxias
Barts and The London School of Medicine and Dentistry
Centre for Neuroscience and Trauma

REINO UNIDO (EL)

Greater London
LONDON

REINO UNIDO (EL)

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
National Hospital for Neurology and Neurosurgery
Department of Molecular Neuroscience

REINO UNIDO (EL)

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
University College London Hospitals, NHS Foundation Trust
Department of Chemical Pathology

REINO UNIDO (EL)

Lothian
EDINBURGH

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
PMARC - The University of Edinburgh
Perception-Movement-Action Research Consortium

REINO UNIDO (EL)

Lothian
EDINBURGH

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
School of Informatics, The University of Edinburgh
Human Communication Research Centre

REINO UNIDO (EL)

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Churchill Hospital
Department of Clinical Genetics

REINO UNIDO (EL)

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Churchill Hospital
Oxford Medical Genetics Laboratories

REINO UNIDO (EL)

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Henry Wellcome Building for Molecular Physiology
BRC Genetics and Pathology Theme

REINO UNIDO (EL)

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Le Gros Clark Building - University of Oxford
MRC Functional Genetics Unit

ALEMANIA

Baden-Württemberg
TÜBINGEN

Financiado por un miembro del IRDiRCNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Medizinische Genetik und angewandte Genomik Tübingen
Institut für Medizinische Genetik und angewandte Genomik

ALEMANIA

Nordrhein-Westfalen
BONN

ALEMANIA

Nordrhein-Westfalen
KÖLN

Financiado por un miembro del IRDiRCNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Humangenetik am Universitätsklinikum Köln
Institut für Humangenetik

ESTADOS UNIDOS

Arizona
PHOENIX

Financiado por un miembro del IRDiRCThe etiology of inherited neurological diseases
Phoenix Children's Hospital
Barrow Neurological Institute

FRANCIA

ILE-DE-FRANCE
PARIS

Financiado por un miembro del IRDiRCNeuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases - FR
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

ITALIA

LOMBARDIA
MILANO

Financiado por un miembro del IRDiRCNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - IT
Università degli Studi di Milano - Scienze Farmacologiche e Biomolecolari
Laboratorio di Biologia delle Cellule Staminali

PAISES BAJOS (LOS)

Zuid-Holland
LEIDEN

REINO UNIDO (EL)

Greater Manchester
ADDRESS: NOT PROVIDED - UK

FRANCIA

ILE-DE-FRANCE
PARIS

Financiado por un miembro del IRDiRCSTaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR
Muséum National d'Histoire Naturelle
Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FRANCIA

PAYS DE LA LOIRE
NANTES

Financiado por un miembro del IRDiRCFROGH : FRench Regional Origins in Genetics for Health - FR
Institut de Recherche en Santé - Université de Nantes
L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

ITALIA

CAMPANIA
NAPOLI

Financiado por un miembro del IRDiRCTelethon Undiagnosed Disease Program - Revised Proposal
TIGEM - Telethon Institute of Genetics and Medicine
Genomic Medicine - Telethon Institute of Genetics and Medicine

JAPON

JAPAN
ADDRESS : NOT PROVIDED - JP

JAPON

JAPAN
ADDRESS : NOT PROVIDED - JP

REINO UNIDO (EL)

Lothian
EDINBURGH

Genetic disorders of human brain development
Western General Hospital
MRC Human Genetics Unit

REINO UNIDO (EL)

Oxfordshire
OXFORD

ALEMANIA

Bayern
MÜNCHEN

Financiado por un miembro del IRDiRCRHAPSODY - Research to Assess Policies and Strategies for Dementia in the Young
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für Psychiatrie und Psychotherapie

Proyectos de investigación multicéntricos